Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease 2023-03-31
  2. Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia 2023-02-09

Studies

2 studies carry this tag.

Date range

2023

Top journals

  • Annals of clinical and translational neurology 1
  • NPJ Parkinson's disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Annals of clinical and translational neurology 2023-03-31 Biomarkers

    Linear models showed that plasma GFAP was significantly higher in αSyn+AD compared to αSyn (β = 0.31, 95% CI = 0.065-0.56, and P = 0.015), after covarying for age at plasma, plasma-to-death interval, and sex; plasma p-tau 181 was not (P = 0.37).

  2. Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. NPJ Parkinson's disease 2023-02-09 Biomarkers

    Glial fibrillary acidic protein (GFAP) has been suggested as a biomarker for reactive astrogliosis.

All topic tags with their study counts